Evidence map›Paper›PMID 27103117›Full record

ArticleJournal of primary care & community health2016

A Pilot Study for Understanding the Perceptions of Australian General Practitioners Regarding Psychopharmacology for Children With Autism Spectrum Disorders.

Pankaj Garg, David Lillystone, David Dossetor, John Eastwood, Siaw-Teng Liaw

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of primary care & community health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Autism in Australia: Community Knowledge and Autistic People's Experiences.Journal of autism and developmental disorders · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Pankaj GargSchool of Women's and Children's Health, UNSW, Australia Discipline of Paediatrics and Child Health, University of Sydney, Australia Ingham Institute of Applied Medicine, Liverpool, New South Wales, Australia pankaj.garg@sydney.edu.au.
David LillystoneDiscipline of Paediatrics and Child Health, University of Sydney, Australia Hornsby Ku-Ring-Gai Hospital and Hornsby Community Child Health Centre, Hornsby, New South Wales, Australia.
David DossetorDiscipline of Paediatrics and Child Health, University of Sydney, Australia Sydney Children's Hospital Network, Westmead, New South Wales, Australia.
John EastwoodSchool of Women's and Children's Health, UNSW, Australia Discipline of Paediatrics and Child Health, University of Sydney, Australia Ingham Institute of Applied Medicine, Liverpool, New South Wales, Australia Griffith University, Nathan, Queensland, Australia Sydney Local Health District, Sydney, New South Wales, Australia.
Siaw-Teng LiawSchool of Women's and Children's Health, UNSW, Australia Ingham Institute of Applied Medicine, Liverpool, New South Wales, Australia Academic General Practice Unit, Fairfield Hospital, Fairfield, New South Wales, Australia, Centre for Primary Health Care and Equity, UNSW.
University of Sydney · AUIngham Institute · AUWomen's and Children's Health Network · AUWomen's & Children's Health Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGeneral practitioners (GPs) are increasing involved in the care of children with autism spectrum disorders (ASDs), and prescribe and/or manage psychotropic medications for these children. Few published reports of perceptions of GPs regarding use of these medications exist in the literature.

objectiveQualitative analysis of comments by 177 GPs regarding psychopharmacology use in children with ASDs.

methodsA postal questionnaire survey containing both close- and open-ended questions was conducted in New South Wales, Australia.

resultsRespondent GPs were more likely to be females graduated from Australian medical schools and reported an interest either in child or in mental health. The respondents demonstrated good understanding of the issues surrounding psychopharmacology use in children with ASD based on contemporary literature on this topic. The main themes included concerns regarding medication safety, evidence for their use, and role of these medications as an adjuvant to behavior management. GPs reported a lack of experience of these medications, and would often prescribe only under the supervision of specialists. GPs with greater confidence and involvement with children of ASDs prescribed more medications; whereas GP reporting more concerns with regard to medications prescribed less.

conclusionRespondent GPs have good understanding of psychotropic medications but need support from specialists for managing these medications in children with ASDs. Future larger studies should explore the utility of collaborative models of care for GPs to work in close partnerships with specialists.

Indexed as

Attitude of Health PersonnelGeneral PractitionersAdultAustraliaAutism Spectrum DisorderChildChild Behavior DisordersCross-Sectional StudiesFemaleHumansMaleMiddle AgedPilot ProjectsPsychopharmacologyPsychotropic DrugsPsychotropic Drugsautism spectrum disordersgeneral practitionersmedicationspsychopharmacologypsychotropic

Identifiers

PMID27103117
PMCPMC5932698
OpenAlexW2341355146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.